Anaeropharma Science, Inc.

Anaeropharma Science, Inc.

Anaeropharma Science, Inc.

Anaeropharma Science was established in 2004 to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, recombinant bifidobacterium therapeutics.
Raised
$13.2M
Follow us
Alexa global traffic share
05 Jul 2017

French VC joins $13m round for Japanese biopharma player

AVCJ
+1